Lupus

Article	Citations
10 Years of belimumab experience: What have we learnt?	74
Adult systemic lupus erythematosus in Egypt: The nation-wide spectrum of 3661 patients and world-wide standpoint	55
Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohort	52
Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus	50
Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK	30
Systemic lupus erythematosus: The search for the ideal biomarker	28
Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort	25
Immune thrombocytopenia and COVID-19: Case report and review of literature	24
Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activity	23
Lupus, vaccinations and COVID-19: What we know now	22
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)	22
Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis	22
The importance of pregnancy planning in lupus pregnancies	21
Erosive arthritis in systemic lupus erythematosus: not only Rhupus	21
Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study	20
Rituximab – The first twenty years	19
Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study	19
Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel	19
Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis	19
Medication adherence is influenced by resilience in patients with systemic lupus erythematosus	18
The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients	18
Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis	18
Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study	18
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study	18
Safety and efficacy of telitacicept in refractory childhood-onset systemic lupus erythematosus: A self-controlled before–after trial	17

Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study	17
Evaluation of subclinical retinal microvascular changes in systemic lupus erythematosus patients using optical coherence tomography angiography and its relationship with disease activity	16
A home-based exercise program during COVID-19 pandemic: Perceptions and acceptability of juvenile systemic lupus erythematosus and juvenile idiopathic arthritis adolescents.	16
Albumin-to-globulin ratio (AGR) as a potential marker of predicting lupus nephritis in Chinese patients with systemic lupus erythematosus	16
Identification of ferroptosis-related molecular markers in glomeruli and tubulointerstitium of lupus nephritis	16
Systemic lupus erythematosus and pregnancy: A retrospective single-center study of 215 pregnancies from Portugal	16
Cognitive impairment in systemic lupus erythematosus is negatively related to social role participation and quality of life: A systematic review	16
Clinical pharmacology considerations for the approval of belimumab for the treatment of adult patients with active lupus nephritis: A regulatory perspective	16
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom	16
Low disease activity state in juvenile-onset systemic lupus erythematosus	15
The association of lupus nephritis with adverse pregnancy outcomes among women with lupus in North America	15
Something new about prognostic factors for lupus nephritis? A systematic review	15
COVID-19 in patients with systemic lupus erythematosus: A systematic review	15
Patient experiences and strategies for coping with SLE: A qualitative study	14
Low expression of estrogen receptor β in renal tubular epithelial cells may cause hyperuricemia in premenopausal patients with systemic lupus erythematosus	14
Three functional variants in the NLRP3 gene are associated with susceptibility and clinical characteristics of systemic lupus erythematosus	14
An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States	13
A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patients	13
Systemic lupus erythematosus patients have a distinct structural and functional skin microbiota compared with controls	13
Damage index for antiphospholipid syndrome during long term follow-up: Correlation between organ damage accrual and quality of life	13
Myositis in systemic lupus erythematosus	13
EBV load is associated with cfDNA fragmentation and renal damage in SLE patients	13
Pediatric systemic lupus erythematosus with lupus anticoagulant hypoprothrombinemia syndrome—A case series with review of literature	12
Ofatumumab use in juvenile systemic lupus erythematosus: A single centre experience	12
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome	12
Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders	12
The new 2019-EULAR/ACR classification criteria specific domains at diagnosis can predict damage accrual in 670 childhood-onset systemic lupus erythematosus patients	12
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome	12
Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus: a cross-sectional study compared with healthy controls	12
COVID-19 in systemic lupus erythematosus: A pooled analysis and systematic review of case reports and series	12
Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients	12
Systemic erythematosus lupus and pregnancy outcomes in a Colombian cohort	11
Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study	11
New-onset lupus nephritis associated with COVID-19 infection	11
Outcome of clinical and subclinical myocardial injury in systemic lupus erythematosus – A prospective cohort study	11
Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus	11
Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study	11
Bioinformatic analysis of key biomarkers and immune filtration of skin biopsy in discoid lupus erythematosus	11
Incidence and prevalence of systemic lupus erythematosus among Korean women in childbearing years: A nationwide population-based study	11
Direct oral anticoagulants versus warfarin in patients with antiphospholipid syndrome: A meta-analysis of randomized controlled trials	11
Exploration of machine learning methods to predict systemic lupus erythematosus hospitalizations	11
Rituximab use in pediatric systemic lupus erythematosus: Indications, efficacy and safety in an Indian cohort	10
Cytokines, 25-OH vit D and disease activity in patients with juvenile-onset systemic lupus erythematosus	10
Targets of Tripterygium glycosides in systemic lupus erythematosus treatment: A network-pharmacology study	10
Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis	10
Systemic lupus erythematosus in children and adults: A retrospective study in Brazilian patients	10
CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: A hospital-based case-control study	10
The association between lupus serology and disease outcomes: A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus	10
Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study	10
Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus	10

Antiphospholipid syndrome–mediated acute cerebrovascular diseases and long-term outcomes	10
Impact of the first wave of the COVID-19 pandemic on systemic lupus erythematosus patients: Results from a multi-center prospective cohort	10
Health care practitioners’ confidence assessing lupus-related rashes in patients of color	10
MOG-IgG-associated disorder and systemic lupus erythematosus disease: Systematic review	9
Multitarget therapy versus monotherapy as induction treatment for lupus nephritis: A meta-analysis of randomized controlled trials	9
Use of telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak: The 6-month results of a randomized controlled trial	9
Systemic lupus erythematosus children in Egypt: Homeland spectrum amid the global situation	9
Association of MALAT-1 gene single nucleotide polymorphisms with genetic susceptibility to systemic lupus erythematosus	9
Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis	9
Dual trajectories of fatigue and disease activity in an inception cohort of adults with systemic lupus erythematosus over 10 years	9
Nailfold capillaroscopy findings in cutaneous lupus erythematosus patients with or without digital lesions and comparison with dermatomyositis patients: A prospective study	9
Systemic lupus erythematosus and risk of sexual dysfunction: A systematic review and Meta-Analysis	9
Twenty-year trends in all-cause mortality of patients with systemic lupus erythematosus in Mexico: Results from a nationwide health registry	9
Real-world use and outcomes of belimumab in childhood-onset lupus: A single-center retrospective study	9
The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations	9
The relationship between the modified National Institute of Health activity and chronicity scoring system, and the long-term prognosis for lupus nephritis: A retrospective single-center study	9
Elevated apoptosis and abnormal apoptosis signaling of regulatory T cells in patients with systemic lupus erythematosus	9
Systematic review of digital and non-digital non-pharmacological interventions that target quality of life and psychological outcomes in adults with systemic lupus erythematosus	9
Hospitalization in patients with systemic lupus erythematosus at Tawam Hospital, United Arab Emirates (UAE): Rates, causes, and factors associated with length of stay	9
The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States	9
The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosus	9
Childhood Systemic Lupus Erythematosus: Presentation, management and long-term outcomes in an Australian cohort	9
Lower socioeconomic status worsens outcome of patients with systemic lupus erythematosus independently of access to healthcare	9
Antiphospholipid antibodies and idiopathic infertility	9
Unsupervised clustering analysis of data from an online community to identify lupus patient profiles with regards to treatment preferences	9
Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients	8
Association of PER2 gene single nucleotide polymorphisms with genetic susceptibility to systemic lupus erythematosus	8
The effect of Omega-3 fatty acid supplementation in systemic lupus erythematosus patients: A systematic review	8
Comorbidities of systemic lupus erythematosus prior to and following diagnosis in different age-at-onset groups	8
The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family	8
Omega-3 fatty acids: Current insights into mechanisms of action in systemic lupus erythematosus	8
Plant-based dietary changes may improve symptoms in patients with systemic lupus erythematosus	8
Low health numeracy is associated with higher disease activity in systemic lupus erythematosus	8
Immunoglobulin levels in systemic lupus erythematosus: A narrative review	8
Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus	8
Safety and tolerability of bone marrow–derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humans	8
Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review	8
Systemic lupus erythematosus and COVID-19 during pregnancy	8
Joint involvement influences quality of life in systemic lupus erythematosus patients	8
Correlation between irreversible organ damage and the quality of life of patients with systemic lupus erythematosus: The Kyoto Lupus Cohort survey	8
The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity	8
Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life	8
Distribution of IgG subclass anti-nuclear antibodies (ANAs) in systemic lupus erythematosus	8
Differentiating flare and infection in febrile lupus patients: Derivation and validation of a calculator for resource constrained settings	8
Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome	8
Role of micro-RNA132 and its long non coding SOX2 in diagnosis of lupus nephritis	8
Identifying additional risk factors for arterial and venous thrombosis among pediatric antiphospholipid antibodies carriers	8
Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis	8
Why lupus patients discontinue antimalarials in real life: A 50 years-experience from a reference centre	7
2019 ACR/EULAR classification criteria and therapy in predicting organ damage accrual in patients with childhood-onset systemic lupus erythematosus: A retrospective study over the last 29 years	7
Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance	7
Mental health in patients with rheumatic diseases related to COVID-19 pandemic: Experience in a tertiary care center in Latin America	7
Role of interleukin-6 and interferon-α in systemic lupus erythematosus: A case–control study and meta-analysis	7
Infusion of anti-DFS70 antibodies prolonged survival of lupus-prone mice	7
Increased CD69+CCR7+ circulating activated T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials	7
The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the “Catastrophic antiphospholipid syndrome regis	7
Epidemiology of disease-activity related ophthalmological manifestations in Systemic Lupus Erythematosus: A systematic review	7
Social media as source of information for Spanish-speaking patients with systemic lupus erythematosus	7
Aggravation of discoid lupus erythematosus in a patient with psoriasis and psoriatic arthritis during treatment of secukinumab: A case report and review of literature	7
Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab	7
Pregnancy in patients with systemic lupus erythematosus after cyclophosphamide therapy	7
Description of damage in different clusters of patients with antiphospholipid syndrome	7
Age differences in secular trends in black–white disparities in mortality from systemic lupus erythematosus among women in the United States from 1988 to 2017	7
White matter microstructure alterations in systemic lupus erythematosus: A preliminary coordinate-based meta-analysis of diffusion tensor imaging studies	7
Malignancies among newly diagnosed systemic lupus erythematosus patients and their survival	7
Clinical characteristics of itch in cutaneous lupus erythematosus: A prospective, multicenter, multinational, cross-sectional study	7
Health-related quality of life, fatigue and health utilities in lupus nephritis: A systematic literature review	7
Laboratory-confirmed pediatric COVID-19 in patients with rheumatic diseases: A case series in a tertiary hospital	7
The relation of CD4+CD25+Foxp3+ regulatory T cells concentration with disease activity and damage index in systemic lupus erythematosus	7
Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis	7
Cotrimoxazole prophylaxis prevents major infective episodes in patients with systemic lupus erythematosus on immunosuppressants: A non-concurrent cohort study	7
Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: Contributions to pathogenesis and clinical applications	7
Methyl donor micronutrients, CD40-ligand methylation and disease activity in systemic lupus erythematosus: A cross-sectional association study	7
Prednisone and long-term damage in systemic lupus erythematosus: Which is the threshold dose? A pilot study	7
Sandplay therapy could be a method to decrease disease activity and psychological stress in children with systemic lupus erythematosus	7
Improved pregnancy outcomes in systemic lupus erythematosus: A retrospective study of pregnancies from a single centre in Denmark from 2010–2020 compared with the period 1990–2010	6
Early onset left ventricular remodeling in juvenile systemic lupus erythematosus; Insight from 3-dimensional speckle tracking echocardiography	6
Adverse drug reactions to trimethoprim-sulfamethoxazole in systemic lupus erythematosus	6
Identification and analysis of the predictive urinary exosomal miR-195-5p in lupus nephritis based on renal miRNA-mRNA co-expression network	6
Incidence and prevalence of systemic lupus erythematosus in New Zealand from the national administrative datasets	6

Validation and verification of the Japanese version of the systemic lupus erythematosus symptom checklist for patient quality of life	6
DNA methylation alterations in systemic lupus erythematosus: A systematic review of case-control studies	6
Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE	6
The effect of smoking on cumulative damage in systemic lupus erythematosus: An incident cohort study	6
De novo lupus nephritis after SARS-CoV-2 infection	6
Non-pharmacologic therapies in treatment of childhood-onset systemic lupus erythematosus: A systematic review	6
Comparing pregnancy outcomes in patients with criteria and non-criteria autoimmune disease: A systematic review	6
Aseptic meningitis as initial manifestation of systemic lupus erythematosus: Case series	6
Applying SLICC and ACR/EULAR systemic lupus erythematosus classification criteria in a cohort of patients with undifferentiated connective tissue disease	6
Immature platelet levels correlate with disease activity and predict treatment response of thrombocytopenia in lupus patients	6
Addressing health disparities as a function of ethnicity in systemic lupus erythematosus patients	6
Brain network reorganisation and spatial lesion distribution in systemic lupus erythematosus	6
KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro	6
Hematologic manifestations of juvenile systemic lupus erythematosus: An emphasis on anemia	6
Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure	6
The challenges in diagnosing pediatric primary antiphospholipid syndrome	6
Differences in quality of life in patients with cutaneous lupus erythematosus with varying income levels	6
Catastrophic antiphospholipid syndrome presented as ruptured papillary muscle during puerperium in a patient with systemic lupus erythematosus	6
mRNA expression analysis confirms CD44 splicing impairment in systemic lupus erythematosus patients	6
The impact of low muscle function on health-related quality of life in Indonesian women with systemic lupus erythematosus	6
Vitamin D levels in Greek patients with systemic lupus erythematosus	6
Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer	6
Identification and stratification of systemic lupus erythematosus patients into two transcriptionally distinct clusters based on IFN-I signature	6
Prevalence of migraine in systemic lupus erythematosus: A meta-analysis	6
Lupus band test for diagnostic evaluation in systemic lupus erythematosus	6
Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review	6
Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample	6
Safety of tacrolimus use during pregnancy and related pregnancy outcomes in patients with systemic lupus erythematosus: A retrospective single-center analysis in Japan	6
Induced abortions in women with systemic lupus erythematosus	6
Posterior reversible encephalopathy syndrome in juvenile lupus- a case series and literature review	6
Jaccoud-type lupus arthropathy	6
Association of the premature immunosenescence with the presence and severity of anemia among patients with systemic lupus erythematosus	6
Factors mediating cancer risk in systemic lupus erythematosus	6
Association of microRNA-125a with the clinical features, disease activity and inflammatory cytokines of juvenile-onset lupus patients	6
Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience	5
Serum and urinary galectin-9 and C-X-C motif chemokine ligand 10	5
Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus	5
Predictive models of infection in patients with systemic lupus erythematosus: A systematic literature review	5
Metabolic syndrome predicts new damage in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort	5
Kidney transplantation outcomes in lupus nephritis: A 37-year single-center experience from Latin America	5
Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus	5
Platelet- and endothelial-derived microparticles in the context of different antiphospholipid antibody profiles	5
Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications	5
Evaluation of urinary FOXP3 mRNA as a biomarker of lupus nephritis in Egyptian patients with systemic lupus erythematosus	5
Plasma checkpoint protein levels and galectin-9 in juvenile systemic lupus erythematosus	5
Dysregulation of tRNA-derived small RNAs and their potential roles in lupus nephritis	5
Symptomatic osteonecrosis of the hip and knee in patients with systemic lupus erythematosus: Prevalence, pattern, and comparison of natural course	5
The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab	5
Exploring the relationship between systemic lupus erythematosus and osteoporosis based on bioinformatics	5
Significant hypomethylation of MMP9 gene promoter in patients with systemic lupus erythematosus	5
The pathogenic role of lupus-specific autoantibodies and Interleukin-6 on demyelination of the brainstem and spinal cord in systemic lupus erythematosus	5
Performance analysis of Luminex and ELISA to profile serum IP-10 as a biomarker in systemic lupus erythematosus	5
The changes in bone turnover markers of female systemic lupus erythematousus patients without glucocorticoid	5
Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome	5
A novel therapeutic approach using the Zipper method to treat chorea in a pediatric-onset systemic lupus erythematosus patient	5
Breastfeeding in women affected by systemic lupus erythematosus: Rate, duration and associated factors	5
Montreal cognitive assessment as a screening instrument for cognitive impairment in systemic lupus erythematosus patients without overt neuropsychiatric manifestations	5
Combined treatment of prednisone and hydroxychloroquine may improve outcomes of frozen embryo transfer in antinuclear antibody-positive patients undergoing IVF/ICSI treatment	5
Systemic lupus erythematosus during pregnancy is not associated with school performance in offspring – A Danish population-based study	5
Association between alcohol intake and the risk of systemic lupus erythematosus: A systematic review and meta-analysis	5
Prognostic factors of systemic lupus erythematosus patients with pulmonary embolism: An 11-year cohort study	5
Factors affecting sleep quality in patients with systemic lupus erythematosus	5
Improved executive function in patients with systemic lupus erythematosus following interactive digital training	5
Systemic lupus erythematosus-related acute pancreatitis	5
Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus	5
Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis	5
Intrarenal injection of mesenchymal stem cell for treatment of lupus nephritis in mice – a pilot study	5
A prospective study of reproductive factors in relation to risk of systemic lupus erythematosus among black women	5
Prevalence and risk factors for serositis in patients with systemic lupus erythematosus: A case-control study	5
Avoiding misclassification of thrombotic primary antiphospholipid syndrome as systemic lupus erythematosus (SLE): What are the best-performing SLE classification criteria?	5
The SLICC-FI Predicts Damage Accrual in SLE Patients. Data From the Almenara Lupus Cohort	5
Belimumab in subacute cutaneous lupus erythematosus	5
Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus	5
Development and validation of lupus nephritis case definitions using United States veterans affairs electronic health records	5
Hydroxychloroquine use reduces mortality risk in systemic lupus erythematosus: A systematic review and meta-analysis of cohort studies	5